<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39428617</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1520-4995</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Biochemistry</Title><ISOAbbreviation>Biochemistry</ISOAbbreviation></Journal><ArticleTitle>High-Throughput Algorithmic Optimization of <i>In Vitro</i> Transcription for SARS-CoV-2 mRNA Vaccine Production.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1021/acs.biochem.4c00188</ELocationID><Abstract><AbstractText>The <i>in vitro</i> transcription (IVT) of messenger ribonucleic acid (mRNA) from the linearized deoxyribonucleic acid (DNA) template of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) was optimized for total mRNA yield and purity (by percent intact mRNA) utilizing machine learning in conjunction with automated, high-throughput liquid handling technology. An iterative Bayesian optimization approach successfully optimized 11 critical process parameters in 42 reactions across 5 experimental rounds. Once the optimized conditions were achieved, an automated, high-throughput screen was conducted to evaluate commercially available T7 RNA polymerases for rate and quality of mRNA production. Final conditions showed a 12% yield improvement and a 50% reduction in reaction time, while simultaneously significantly decreasing (up to 44% reduction) the use of expensive reagents. This novel platform offers a powerful new approach for optimizing IVT reactions for mRNA production.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>McMinn</LastName><ForeName>Spencer E</ForeName><Initials>SE</Initials><Identifier Source="ORCID">0009-0007-6633-4870</Identifier><AffiliationInfo><Affiliation>Process Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Danielle V</ForeName><Initials>DV</Initials><AffiliationInfo><Affiliation>Process Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yur</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Process Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stone</LastName><ForeName>Kevin</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0003-3750-5072</Identifier><AffiliationInfo><Affiliation>Process Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Yuting</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Biometrics Research, Merck &amp; Co., Inc., Rahway, New Jersey 07065, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vikram</LastName><ForeName>Ajit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-7397-3431</Identifier><AffiliationInfo><Affiliation>Process Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murali</LastName><ForeName>Shashank</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Process Development, Eurofins PSS, West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raffaele</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Analytical Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holland</LastName><ForeName>David</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2702-7038</Identifier><AffiliationInfo><Affiliation>Analytical Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Sheng-Ching</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Process Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Joseph P</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-0062-2534</Identifier><AffiliationInfo><Affiliation>Process Research and Development, Merck &amp; Co., Inc., West Point, Pennsylvania 19486, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biochemistry</MedlineTA><NlmUniqueID>0370623</NlmUniqueID><ISSNLinking>0006-2960</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>10</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>21</Day><Hour>0</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39428617</ArticleId><ArticleId IdType="doi">10.1021/acs.biochem.4c00188</ArticleId></ArticleIdList></PubmedData></PubmedArticle>